ipilimumab,nivolumab
bms
['sclc', 'nivolumab', 'lung', 'ipilimumab', 'nivo', '9la', 'nsclc']
first-line (1l) nivolumab (nivo) + ipilimumab (ipi) + 2 cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients (pts) with metastatic non small cell lung cancer (nsclc): 3-year update from checkmate 9la #asco22 
Medicina Interna - Oncología Clínica - Profesor Titular @UPBColombia - Clínica Astorga. #Medellín / #Colombia mlujanonco@gmail.com #OncTwitter #Metaanalysis